Cargando…

Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment

Diabetic muscle infarction (DMI) refers to spontaneous ischemic necrosis of skeletal muscle among people with diabetes mellitus, unrelated to arterial occlusion. People with DMI may have coexisting end-stage renal disease (ESRD) but little is known about its epidemiology and clinical outcomes in thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yong, Tuck Yean, Khow, Kareeann Sok Fun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838415/
https://www.ncbi.nlm.nih.gov/pubmed/29527509
http://dx.doi.org/10.5527/wjn.v7.i2.58
_version_ 1783304253694017536
author Yong, Tuck Yean
Khow, Kareeann Sok Fun
author_facet Yong, Tuck Yean
Khow, Kareeann Sok Fun
author_sort Yong, Tuck Yean
collection PubMed
description Diabetic muscle infarction (DMI) refers to spontaneous ischemic necrosis of skeletal muscle among people with diabetes mellitus, unrelated to arterial occlusion. People with DMI may have coexisting end-stage renal disease (ESRD) but little is known about its epidemiology and clinical outcomes in this setting. This scoping review seeks to investigate the characteristics, clinical features, diagnostic evaluation, management and outcomes of DMI among people with ESRD. Electronic database (PubMed/MEDLINE, CINAHL, SCOPUS and EMBASE) searches were conducted for (“diabetic muscle infarction” or “diabetic myonecrosis”) and (“chronic kidney disease” or “renal impairment” or “dialysis” or “renal replacement therapy” or “kidney transplant”) from January 1980 to June 2017. Relevant cases from reviewed bibliographies in reports retrieved were also included. Data were extracted in a standardized form. A total of 24 publications with 41 patients who have ESRD were included. The mean age at the time of presentation with DMI was 44.2 years. Type 2 diabetes was present in 53.7% of patients while type 1 in 41.5%. In this cohort, 60.1% were receiving hemodialysis, 21% on peritoneal dialysis and 12.2% had kidney transplantation. The proximal lower limb musculature was the most commonly affected site. Muscle pain and swelling were the most frequent manifestation on presentation. Magnetic resonance imaging (MRI) provided the most specific findings for DMI. Laboratory investigation findings are usually non-specific. Non-surgical therapy is usually used in the management of DMI. Short-term prognosis of DMI is good but recurrence occurred in 43.9%. DMI is an uncommon complication in patients with diabetes mellitus, including those affected by ESRD. In comparison with unselected patients with DMI, the characteristics and outcomes of those with ESRD are generally similar. DMI may also occur in kidney transplant recipients, including pancreas-kidney transplantation. MRI is the most useful diagnostic investigation. Non-surgical treatment involving analgesia, optimization of glycemic control and initial bed rest can help to improve recovery rate. However, recurrence of DMI is relatively frequent.
format Online
Article
Text
id pubmed-5838415
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-58384152018-03-09 Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment Yong, Tuck Yean Khow, Kareeann Sok Fun World J Nephrol Minireviews Diabetic muscle infarction (DMI) refers to spontaneous ischemic necrosis of skeletal muscle among people with diabetes mellitus, unrelated to arterial occlusion. People with DMI may have coexisting end-stage renal disease (ESRD) but little is known about its epidemiology and clinical outcomes in this setting. This scoping review seeks to investigate the characteristics, clinical features, diagnostic evaluation, management and outcomes of DMI among people with ESRD. Electronic database (PubMed/MEDLINE, CINAHL, SCOPUS and EMBASE) searches were conducted for (“diabetic muscle infarction” or “diabetic myonecrosis”) and (“chronic kidney disease” or “renal impairment” or “dialysis” or “renal replacement therapy” or “kidney transplant”) from January 1980 to June 2017. Relevant cases from reviewed bibliographies in reports retrieved were also included. Data were extracted in a standardized form. A total of 24 publications with 41 patients who have ESRD were included. The mean age at the time of presentation with DMI was 44.2 years. Type 2 diabetes was present in 53.7% of patients while type 1 in 41.5%. In this cohort, 60.1% were receiving hemodialysis, 21% on peritoneal dialysis and 12.2% had kidney transplantation. The proximal lower limb musculature was the most commonly affected site. Muscle pain and swelling were the most frequent manifestation on presentation. Magnetic resonance imaging (MRI) provided the most specific findings for DMI. Laboratory investigation findings are usually non-specific. Non-surgical therapy is usually used in the management of DMI. Short-term prognosis of DMI is good but recurrence occurred in 43.9%. DMI is an uncommon complication in patients with diabetes mellitus, including those affected by ESRD. In comparison with unselected patients with DMI, the characteristics and outcomes of those with ESRD are generally similar. DMI may also occur in kidney transplant recipients, including pancreas-kidney transplantation. MRI is the most useful diagnostic investigation. Non-surgical treatment involving analgesia, optimization of glycemic control and initial bed rest can help to improve recovery rate. However, recurrence of DMI is relatively frequent. Baishideng Publishing Group Inc 2018-03-06 2018-03-06 /pmc/articles/PMC5838415/ /pubmed/29527509 http://dx.doi.org/10.5527/wjn.v7.i2.58 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Minireviews
Yong, Tuck Yean
Khow, Kareeann Sok Fun
Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment
title Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment
title_full Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment
title_fullStr Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment
title_full_unstemmed Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment
title_short Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment
title_sort diabetic muscle infarction in end-stage renal disease: a scoping review on epidemiology, diagnosis and treatment
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838415/
https://www.ncbi.nlm.nih.gov/pubmed/29527509
http://dx.doi.org/10.5527/wjn.v7.i2.58
work_keys_str_mv AT yongtuckyean diabeticmuscleinfarctioninendstagerenaldiseaseascopingreviewonepidemiologydiagnosisandtreatment
AT khowkareeannsokfun diabeticmuscleinfarctioninendstagerenaldiseaseascopingreviewonepidemiologydiagnosisandtreatment